Chain Drug Review - FDA Approves Generic Versions Of Pfizer Inc.’s Cardura Tablets
Several generic drug companies have received approval for doxazosin mesylate tablets, the generic version of Pfizer Inc.’s Cardura. The product is for treating benign prostatic hyperplasis and general hypertension. Receiving Food and Drug Administration marketing clearance were Apotex Corp., KV Pharmaceutical Co., Faulding Inc., Teva Pharmaceuticals USA and Watson Pharmaceuticals Inc.
Related Results
Four strengths of doxazosin approvedTeva, Apotex gain approval for doxazosinDoxazosin helps fight metabolic syndromeIvax receives tentative approval for doxazosin mesylate tabletsFinasteride and doxazosin combo halts BPH progress in 67%
COPYRIGHT 2000 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
